Evaluating hydrological alterations and recommending minimum flow release from the Ujjani dam to improve the Bhima River ecosystem health

Numerous anthropogenic activities like the construction of large dams, storages, and barrages changed the watershed characteristics impacting ecosystem health. In this study, the hydrological alterations (HAs) that have occurred in the Bhima River due to the construction of the Ujjani dam were analyzed. The hydraulic analysis is also performed to determine the hydraulic parameter and recommend the lowest flow release from the dam for improving ecosystem health. Fifty-eight years of data starting from the year 1960 to 2018 were gathered at Yadgir station, which is located downstream of the Ujjani dam. The data were divided into pre- and post-construction river flow discharge. To check for the change in the river flow regime for the post-dam construction period, HA was calculated using Flow Health Software (FHS). The results demonstrate that the dam impoundment reduces high flows primarily by storing flood flow for water supply, irrigation, etc. The velocity and depth provided by the environmental design flow for a flow health (FH) score of 0.62 give a very good habitat to fishes. A minimum release of 24.8 m3/s from the dam is recommended. This study will help policymakers mitigate the impacts of degrading ecosystem health of the Bhima River. HIGHLIGHTS The study analyzes hydrological alterations caused by the construction dam, which have disturbed the river flow regime.; A hydraulic study was performed to determine the hydraulic parameter and to recommend the lowest flow release from the dam for habitat context.; Pre- and post-construction river flow discharge data were used to analyse the impact of human activities on ecology of river.

Design, synthesis, anticancer evaluation and molecular docking studies of 1,2,3-triazole incorporated 1,3,4-oxadiazole-Triazine derivatives

A new library of 1,2,3-triazole-incorporated 1,3,4-oxadiazole-triazine derivatives (9a-j) was designed, synthesized, and tested in vitro for anticancer activity against PC3 and DU-145 (prostate cancer), A549 (lung cancer), and MCF-7 (breast cancer) cancer cell lines using the MTT assay with etoposide as the control drug. The compounds exhibited remarkable anticancer activity, with IC50 values ranging from 0.16 ± 0.083 μM to 11.8 ± 7.46 μM, whereas the positive control ranged from 1.97 0.45 μM to 3.08 0.135 μM. Compound 9 d with a 4-pyridyl moiety shown exceptional anticancer activity against PC3, A549, MCF-7, and DU-145 cell lines, with IC50 values of 0.17 ± 0.063 μM, 0.19 ± 0.075 μM, 0.51 ± 0.083 μM, and 0.16 ± 0.083 μM, respectively